Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 8, 1997, Pages 525-530

  Nishiuma, S ^a   Kario, K ^c   Nakanishi, K ^a   Yakushijin, K ^a   Kageyama, G ^a   Matsunaka, T ^a   Matsuo, T ^b   Kanai, N ^c   Ikeda, U ^c   Shimada, K ^c   Matsuo, M ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Factor VII R353Q polymorphism; Japanese; Lacunar stroke; MRI

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

EID: 6844239559     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199711000-00007     Document Type: Article

References (31)

1. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
2. Meade TW, Ruddock V, Stirling Y, Chakrabarti RR, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischeamic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079.
3. Takano K, Yamaguchi T, Okada Y, Uchida K, Kisiel W, Kato H. Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reaction in plasma by a highly sensitive automated method. Thromb Res 1990; 58: 481-491.
4. Kario K, Matsuo T. High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system. J Cardiovasc Risk 1994; 1: 165-171.
5. Marmot MG, Smith GD. Why are the Japanese living longer? Brit Med J 1989; 299: 1547-1551.
6. Whisnant JP, Basford JR, Bernstein EF, Cooper ES, Dyken ML, Easton JD, et al. for the National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Classification of cerebrovascular disorders III. Stroke 1990; 21: 637-676.
7. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor Vila in hemophilia A and hemophilia B patients. Blood 1992; 80: 25-28.
8. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantification of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744.
9. Kario K, Miyata T, Sakata T, Matsuo T, Kato H. Fluorogenic assay of activated factor VII: Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. Arterioscler Thromb 1994; 14: 265-274.
10. Philipou H, Adami A, Amersey RA, Stubbs PJ, Lane DA. A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndrome. Blood 1997; 89: 767-775.
11. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation, evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-10824.
12. Kario K, Sakata T, Matsuo T, Miyata T. Factor VII in non-insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 342: 1552.
13. Kario K, Matsuo T, Sakata T, Miyata T. Factor VII hyperactivity and ischaemic heart disease. Lancet 1994; 343: 233.
14. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546.
15. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and enviromental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50.
16. Humphries SE, Lane A, Dawson S, Green F. The study of gene-eviroment interactions that influence thrombosis and fibrinolysis. Arch Pathol Lab Med 1992; 116: 1322-1329.
17. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198.
18. Kario K, Narita N, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, et al. Genetic determinants of plasma factor VII activity in the Japanese. Thromb Haemost 1995; 73: 617-622.
19. Takano K, Yamaguchi T, Okada Y, Uchida K, Kisiel W, Kato H. Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res 1990; 58: 481-491.
20. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension 1990; 16: 692-699.
21. Kanai N, Fujii T, Saito K, Yokoyama T. Rapid and simple method for preparation of genomic DNA from easily obtainable clotted blood. J Clin Pathol 1994; 47: 1043-1044.
22. Kario K, Kanai N, Saito K, Matsuo T, Nago N, Shimada K. Ischemic stroke and the gene of angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996; 93: 1630-1633.
23. Nishiuma S, Kario K, Kayaba K, Nago N, Shimada K, Matsuo T, et al. Effect of the angiotensinogen gene Met235 → Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995; 13: 717-722.
24. Yoshida M, Nakamura Y, Higashikawa M, Kinoshita M. Predictors of ischemic stroke in non-rheumatic atrial fibrillation. Int J Cardiol 1996; 56: 61-70.
25. Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, et al. Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-944.
26. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Chapman J, Truffert J, et al. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Haemostasis 1989; 19: 125-130.
27. Miller GJ, Martin JC, Mitropoulos KA, Reeves BE, Thompson RL, Meade TW, et al. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-171
28. Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, et al. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996; 119: 119-127.
29. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5′ region of coagulation factor VII gene (F7) due to an inserted decanucleotide. Hum Genet 1993; 90: 575-576.
30. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vase Biol 1996; 16: 72-76.
31. Brass LM, Isaacsohn JL, Merikangas KR, Robinette D. A study of twins and stroke. Stroke 1992; 23: 221-223.